The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Transcriptional and translational regulation of BACE1 expression—Implications for Alzheimer's disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PPARy is a transcriptional regulator, which acts upon the BACE1 promoter increasing gene expression.”
From BACE1: More than just a β‐secretase (2022) · cites this paper as [54]
In the citing paper
“Additionally, studies showed that NSAIDs, used to decrease inflammation, lower BACE1 activity, likely by reducing PPARy levels.”
From BACE1: More than just a β‐secretase (2022) · cites this paper as [54]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876
Pathways towards and Away from Alzheimer’s Disease
Mattson, M. P. (2004) · Nature · doi:10.1038/nature02621 · Cited by 3,052
Citron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A. Y., Seubert, P., Vigo-Pelfrey, C., Lieberburg, I., & Selkoe, D. J. (1992) · Nature · doi:10.1038/360672a0 · Cited by 1,757
Regulation of translation initiation by FRAP/mTOR
Gingras, A.-C., Raught, B., & Sonenberg, N. (2001) · Genes & Development · doi:10.1101/gad.887201 · Cited by 1,545
Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activity
Yan, R., Bienkowski, M. J., Shuck, M. E., Miao, H., Tory, M. C., Pauley, A. M., Brashler, J. R., Stratman, N. C., Mathews, W. R., Buhl, A. E., et al. (1999) · Nature · doi:10.1038/990107 · Cited by 1,438
Lehmann, J. M., Lenhard, J. M., Oliver, B. B., Ringold, G. M., & Kliewer, S. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.6.3406 · Cited by 1,110
Tau pathology in Alzheimer disease and other tauopathies
Iqbal, K., del C. Alonso, A., Chen, S., Chohan, M. O., El-Akkad, E., Gong, C.-X., Khatoon, S., Li, B., Liu, F., Rahman, A., et al. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.09.008 · Cited by 1,037
Research works printed but not linked: 153
- Aisen, 2003, Effects of rofecoxib or naproxen vs. placebo on Alzheimer disease progression: a randomized controlled trial, JAMA, 289, 2819, 10.1001/jama.289.21.2819 · DOI · Paper page
- Allinson, 2003, ADAMs family members as amyloid precursor protein alpha-secretases, J. Neurosci. Res., 74, 342, 10.1002/jnr.10737 · DOI · Paper page
- Ammendola, 1992, Sp1 DNA binding efficiency is highly reduced in nuclear extracts from aged rat tissues, J. Biol. Chem., 267, 17944, 10.1016/S0021-9258(19)37134-0 · DOI
- Apelt, 2004, Aging-related increase in oxidative stress correlates with developmental pattern of beta-secretase activity and beta-amyloid plaque formation in transgenic Tg2576 mice with Alzheimer-like pathology, Int. J. Dev. Neurosci., 22, 475, 10.1016/j.ijdevneu.2004.07.006 · DOI · Paper page
- Arendt, 2003, Synaptic plasticity and cell cycle activation in neurons are alternative effector pathways: the ‘Dr. Jekyll and Mr. Hyde concept’ of Alzheimer's disease or the yin and yang of neuroplasticity, Prog. Neurobiol., 71, 83, 10.1016/j.pneurobio.2003.09.007 · DOI · Paper page
- Basha, 2005, The fetal basis of amyloidogenesis: exposure to lead and latent overexpression of amyloid precursor protein and beta-amyloid in the aging brain, J. Neurosci., 25, 823, 10.1523/JNEUROSCI.4335-04.2005 · DOI · Paper page
- Bigl, 2000, Expression of beta-secretase mRNA in transgenic Tg2576 mouse brain with Alzheimer plaque pathology, Neurosci. Lett., 292, 107, 10.1016/S0304-3940(00)01452-X · DOI
- Blasko, 2001, Ibuprofen decreases cytokine-induced amyloid beta production in neuronal cells, Neurobiol. Dis., 8, 1094, 10.1006/nbdi.2001.0451 · DOI
- Blasko, 2004, Experimental traumatic brain injury in rats stimulates the expression, production and activity of Alzheimer's disease beta-secretase (BACE-1), J. Neural Transm., 111, 523, 10.1007/s00702-003-0095-6 · DOI · Paper page
- Bodendorf, 2001, A splice variant of beta-secretase deficient in the amyloidogenic processing of the amyloid precursor protein, J. Biol. Chem., 276, 12019, 10.1074/jbc.M008861200 · DOI · Paper page
- Bourne, K.Z., Lange-Dohna, C., Roßner, S., Perez-Polo, J.R., in press. Rat BACE1 promoter nuclear factor-κB binding characterization. J. Neurosci. Res.
- Breidert, 2002, Protective action of the peroxisome proliferator-activated receptor-gamma agonist pioglitazone in a mouse model of Parkinson's disease, J. Neurochem., 82, 615, 10.1046/j.1471-4159.2002.00990.x · DOI · Paper page
- Buxbaum, 1998, Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor, J. Biol. Chem., 273, 27765, 10.1074/jbc.273.43.27765 · DOI · Paper page
- Cai, 2001, BACE1 is the major beta-secretase for generation of Abeta peptides by neurons, Nat. Neurosci., 4, 233, 10.1038/85064 · DOI · Paper page
- Camacho, 2004, Peroxisome-proliferator-activated receptor gamma induces a clearance mechanism for the amyloid-beta peptide, J. Neurosci., 24, 10908, 10.1523/JNEUROSCI.3987-04.2004 · DOI · Paper page
- Camandola, 2000, The lipid peroxidation product 4-hydroxy-2,3-nonenal inhibits constitutive and inducible activity of nuclear factor kappa B in neurons, Mol. Brain Res., 85, 53, 10.1016/S0169-328X(00)00234-5 · DOI
- Campbell, 2004, Post-translational modification of RelA(p65) NF-kappaB, Biochem. Soc. Trans., 32, 1087, 10.1042/BST0321087 · DOI
- Cao, 2001, A transcriptively active complex of APP with Fe65 and histone acetyltransferase tip60, Science, 293, 115, 10.1126/science.1058783 · DOI · Paper page
- Chernak, 1997, Interaction of nuclear factors from young and old rat brain regions with regulatory sequences of the D2 dopamine receptor gene promoter, Mol. Brain Res., 44, 113, 10.1016/S0169-328X(96)00197-0 · doi:10.1016/s0169-328x(96)00197-0
- Christensen, 2004, Transcriptional regulation of BACE1, the beta-amyloid precursor protein beta-secretase, by Sp1, Mol. Cell Biol., 24, 865, 10.1128/MCB.24.2.865-874.2004 · DOI · Paper page
- Citron, 2004, beta-Secretase inhibition for the treatment of Alzheimer's disease—promise and challenge, Trends Pharmacol. Sci., 25, 92, 10.1016/j.tips.2003.12.004 · DOI · Paper page
- Citron, 1995, Generation of amyloid beta protein from its precursor is sequence specific, Neuron, 14, 661, 10.1016/0896-6273(95)90323-2 · DOI · Paper page
- Clemens, 1999, Translational control: the cancer connection, Int. J. Biochem. Cell Biol., 31, 1, 10.1016/S1357-2725(98)00127-7 · DOI · Paper page
- Combs, 2000, Inflammatory mechanisms in Alzheimer's disease: inhibition of β-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARγ agonists, J. Neurosci., 20, 558, 10.1523/JNEUROSCI.20-02-00558.2000 · DOI · Paper page
- Cunard, 2002, Regulation of cytokine expression by ligands of peroxisome proliferator activated receptors, J. Immunol., 168, 2795, 10.4049/jimmunol.168.6.2795 · DOI · Paper page
- d’Abramo, 2005, Role of peroxisome proliferator-activated receptor gamma in amyloid precursor protein processing and amyloid beta-mediated cell death, Biochem. J., 391, 693, 10.1042/BJ20050560 · DOI
- Daynes, 2002, Emerging roles of PPARs in inflammation and immunity, Nat. Rev. Immunol., 2, 748, 10.1038/nri912 · DOI · Paper page
- Dehmer, 2004, Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activation, J. Neurochem., 88, 494, 10.1046/j.1471-4159.2003.02210.x · DOI · Paper page
- De Pietri Tonelli, 2004, Translational regulation of BACE-1 expression in neuronal and non-neuronal cells, Nucleic Acids Res., 32, 1808, 10.1093/nar/gkh348 · DOI
- Dermaut, 2005, Tau is central in the genetic Alzheimer-frontotemporal dementia spectrum, Trends Genet., 21, 664, 10.1016/j.tig.2005.09.005 · DOI
- De Strooper, 2000, Proteolytic processing and cell biological functions of the amyloid precursor protein, J. Cell Sci., 113, 1857, 10.1242/jcs.113.11.1857 · DOI · Paper page
- Diab, 2002, Peroxisome proliferator-activated receptor-gamma agonist 15-deoxy-delta(12,14)-prostaglandin J(2) ameliorates experimental autoimmune encephalomyelitis, J. Immunol., 168, 2508, 10.4049/jimmunol.168.5.2508 · DOI · Paper page
- Donohoe, 1999, Targeted disruption of mouse Yin Yang 1 transcription factor results in peri-implantation lethality, Mol. Cell Biol., 19, 7237, 10.1128/MCB.19.10.7237 · DOI · Paper page
- Dunah, 2002, Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease, Science, 296, 2238, 10.1126/science.1072613 · DOI · Paper page
- Farber, 1995, Regulated secretion of β-amyloid precursor protein in rat brain, J. Neurosci., 15, 7442, 10.1523/JNEUROSCI.15-11-07442.1995 · DOI · Paper page
- Farzan, 2000, BACE2, a beta-secretase homolog, cleaves at the beta site and within the amyloid-beta region of the amyloid-beta precursor protein, Proc. Natl. Acad. Sci. U.S.A., 97, 9712, 10.1073/pnas.160115697 · DOI · Paper page
- Feinstein, 2002, Peroxisome proliferator-activated receptor-gamma agonists prevent experimental autoimmune encephalomyelitis, Ann. Neurol., 51, 694, 10.1002/ana.10206 · DOI · Paper page
- Fuentealba, 2004, Signal transduction during amyloid-beta-peptide neurotoxicity: role in Alzheimer disease, Brain Res. Rev., 47, 275, 10.1016/j.brainresrev.2004.07.018 · DOI
- Fukumoto, 2002, Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease, Arch. Neurol., 59, 1381, 10.1001/archneur.59.9.1381 · DOI · Paper page
- Gau, 2002, Stable beta-secretase activity and presynaptic cholinergic markers during progressive central nervous system amyloidogenesis in Tg2576 mice, Am. J. Pathol., 160, 731, 10.1016/S0002-9440(10)64893-6 · DOI
- Gimble, 1996, Peroxisome proliferator-activated receptor-gamma activation by thiazolidinediones induces adipogenesis in bone marrow stromal cells, Mol. Pharmacol., 50, 1087
- Glasgow, 2000, One path to cell death in the nervous system, Neurochem. Res., 25, 1373, 10.1023/A:1007612716591 · DOI
- Glenner, 1984, Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein, Biochem. Biophys. Res. Commun., 120, 885, 10.1016/S0006-291X(84)80190-4 · DOI · Paper page
- Gordon, 2003, Yin Yang 1 is a lipopolysaccharide-inducible activator of the murine 3′ Igh enhancer, hs3, J. Immunol., 170, 5549, 10.4049/jimmunol.170.11.5549 · DOI
- Grilli, 1995, Identification and characterization of a kappa B/Rel binding site in the regulatory region of the amyloid precursor protein gene, J. Biol. Chem., 270, 26774, 10.1074/jbc.270.45.26774 · DOI
- Gruninger-Leitch, 2002, Substrate and inhibitor profile of BACE (beta-secretase) and comparison with other mammalian aspartic proteases, J. Biol. Chem., 277, 4687, 10.1074/jbc.M109266200 · DOI · Paper page
- Haass, 2004, Take five—BACE and the gamma-secretase quartet conduct Alzheimer's amyloid beta-peptide generation, EMBO J., 23, 483, 10.1038/sj.emboj.7600061 · DOI · Paper page
- Haass, 1993, b-Amyloid peptide and a 3-kDa fragment are derived by distinct cellular mechanisms, J. Biol. Chem., 268, 3021, 10.1016/S0021-9258(18)53650-4 · DOI · Paper page
- Hahn, 1992, Cloning of the rat gene encoding choline acetyltransferase, a cholinergic neuron-specific marker, Proc. Natl. Acad. Sci. U.S.A., 89, 4387, 10.1073/pnas.89.10.4387 · DOI
- Hardy, 2002, The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics, Science, 297, 353, 10.1126/science.1072994 · DOI · Paper page
- Hartlage-Rübsamen, 2003, Astrocytic expression of the Alzheimer's disease β-secretase (BACE) is stimulus-dependent, Glia, 41, 169, 10.1002/glia.10178 · DOI · Paper page
- Higgins, 1996, P3 beta-amyloid peptide has a unique and potentially pathogenic immunohistochemical profile in Alzheimer's disease brain, Am. J. Pathol., 149, 585
- Hirano, 1998, Functional interference of Sp1 and NF-kappaB through the same DNA binding site, Mol. Cell Biol., 18, 1266, 10.1128/MCB.18.3.1266 · DOI
- Hiromura, 2003, YY1 is regulated by O-linked N-acetylglucosaminylation (O-glcNAcylation), J. Biol. Chem., 278, 14046, 10.1074/jbc.M300789200 · DOI
- Hoffman, 1995, DNA binding and regulatory effects of transcription factors SP1 and USF at the rat amyloid precursor protein gene promoter, Nucleic Acids Res., 23, 2229, 10.1093/nar/23.12.2229 · DOI
- Holsinger, 2002, Increased expression of the amyloid precursor beta-secretase in Alzheimer's disease, Ann. Neurol., 51, 783, 10.1002/ana.10208 · DOI · Paper page
- Hoshi, 1997, Nontoxic amyloid β peptide (1-42) supresses acetylcholine synthesis—possible role in cholinergic dysfunction in Alzheimer's disease, J. Biol. Chem., 272, 2038, 10.1074/jbc.272.4.2038 · DOI
- Hsiao, 1996, Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice, Science, 274, 99, 10.1126/science.274.5284.99 · DOI · Paper page
- Hussain, 1999, Identification of a novel aspartic protease (Asp 2) as beta-secretase, Mol. Cell. Neurosci., 14, 419, 10.1006/mcne.1999.0811 · DOI · Paper page
- Hyde-DeRuyscher, 1995, DNA binding sites for the transcriptional activator/repressor YY1, Nucleic Acids Res., 23, 4457, 10.1093/nar/23.21.4457 · DOI · Paper page
- Inoue, 1993, Enhancer containing unusual GC box-like sequences on the human choline acetyltransferase gene, Mol. Brain Res., 20, 299, 10.1016/0169-328X(93)90056-U · DOI
- Irizarry, 2001, Beta-site APP cleaving enzyme mRNA expression in APP transgenic mice: anatomical overlap with transgene expression and static levels with aging, Am. J. Pathol., 158, 173, 10.1016/S0002-9440(10)63955-7 · DOI
- Jiang, 1998, PPAR-γ agonists inhibit production of monocyte inflammatory cytokines, Nature, 391, 82, 10.1038/35154 · DOI · Paper page
- Jones, 2003, Have cholinergic therapies reached their clinical boundary in Alzheimer's disease?, Int. J. Geriatr. Psychiatry, 18, S7, 10.1002/gps.936 · DOI · Paper page
- Jope, 1996, Cholinergic muscarinic receptor signaling by the phosphoinositide signal transduction system in Alzheimer's disease, Alzheimer's Dis. Rev., 1, 2
- Jope, 1997, Cholinergic activation of phosphoinositide signaling is impaired in Alzheimer's disease brain, Neurobiol. Aging, 18, 111, 10.1016/S0197-4580(96)00205-9 · DOI
- Joseph, 2001, Copernicus revisited: amyloid beta in Alzheimer's disease, Neurobiol. Aging, 22, 131, 10.1016/S0197-4580(00)00211-6 · DOI · Paper page
- Kaltschmidt, 1997, Transcription factor NF-kappaB is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease, Proc. Natl. Acad. Sci. U.S.A., 94, 2642, 10.1073/pnas.94.6.2642 · DOI · Paper page
- Kaltschmidt, 1999, Inhibition of NF-κB potentiates amyloid-β-mediated neuronal apoptosis, Proc. Natl. Acad. Sci. U.S.A., 96, 9409, 10.1073/pnas.96.16.9409 · DOI · Paper page
- Kaltschmidt, 1745, Signaling via NF-kappaB in the nervous system, Biochim. Biophys. Acta, 287
- Kar, 1996, β-amyloid-related peptides inhibit potassium-evoked acetylcholine release from rat hippocampal slices, J. Neurosci., 16, 1034, 10.1523/JNEUROSCI.16-03-01034.1996 · DOI
- Kelly, 1996, Amyloid β peptide disrupts carbachol-induced muscarinic cholinergic signal transduction in cortical neurons, Proc. Natl. Acad. Sci. U.S.A., 93, 6753, 10.1073/pnas.93.13.6753 · DOI · Paper page
- Kitazume, 2005, In vivo cleavage of alpha2,6-sialyltransferase by Alzheimer beta-secretase, J. Biol. Chem., 280, 8589, 10.1074/jbc.M409417200 · DOI · Paper page
- Kitazume, 2003, Characterization of alpha 2,6-sialyltransferase cleavage by Alzheimer's beta-secretase (BACE1), J. Biol. Chem., 278, 14865, 10.1074/jbc.M206262200 · DOI
- Kitazume, 2001, Alzheimer's beta-secretase, beta-site amyloid precursor protein-cleaving enzyme, is responsible for cleavage secretion of a Golgi-resident sialyltransferase, Proc. Natl. Acad. Sci. U.S.A., 98, 13554, 10.1073/pnas.241509198 · DOI · Paper page
- Koike, 1999, Membrane-anchored metalloprotease MDC9 has an alpha-secretase activity responsible for processing the amyloid precursor protein, Biochem. J., 343, 371, 10.1042/0264-6021:3430371 · doi:10.1042/0264-6021:3430371 · Paper page
- Koo, 1994, Evidence that production and release of amyloid beta-protein involves the endocytic pathway, J. Biol. Chem., 269, 17386, 10.1016/S0021-9258(17)32449-3 · DOI · Paper page
- Korhonen, 1997, Glutamate-induced changes in the DNA-binding complexes of transcription factor YY1 in cultured hippocampal and cerebellar granule cells, Mol. Brain Res., 52, 330
- Korhonen, 2005, Changes in DNA binding pattern of transcription factor YY1 in neuronal degeneration, Neurosci. Lett., 377, 121, 10.1016/j.neulet.2004.11.085 · DOI
- Kozak, 1987, An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs, Nucleic Acids Res., 15, 8125, 10.1093/nar/15.20.8125 · DOI · Paper page
- Krabbe, 2004, Inflammatory mediators in the elderly, Exp. Gerontol., 39, 687, 10.1016/j.exger.2004.01.009 · DOI · Paper page
- Krippner-Heidenreich, 2005, Caspase-dependent regulation and subcellular redistribution of the transcriptional modulator YY1 during apoptosis, Mol. Cell Biol., 25, 3704, 10.1128/MCB.25.9.3704-3714.2005 · DOI
- Kukar, 2005, Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Abeta42 production, Nat. Med., 11, 545, 10.1038/nm1235 · DOI · Paper page
- Kwon, 2003, Yin Yang 1, a vertebrate polycomb group gene, regulates antero-posteriorneural patterning, Biochem. Biophys. Res. Commun., 306, 1008, 10.1016/S0006-291X(03)01071-4 · DOI
- Lahiri, 1991, The promoter activity of the gene encoding Alzheimer beta-amyloid precursor protein (APP) is regulated by two blocks of upstream sequences, Mol. Brain Res., 9, 253, 10.1016/0169-328X(91)90009-M · DOI
- Lalowski, 1996, The “nonamyloidogenic” p3 fragment (amyloid beta17-42) is a major constituent of Down's syndrome cerebellar preamyloid, J. Biol. Chem., 271, 33623, 10.1074/jbc.271.52.33623 · DOI
- Lammich, 1999, Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease, Proc. Natl. Acad. Sci. U.S.A., 96, 3922, 10.1073/pnas.96.7.3922 · DOI · Paper page
- Lammich, 2004, Expression of the Alzheimer protease BACE1 is suppressed via its 5′-untranslated region, EMBO Rep., 5, 620, 10.1038/sj.embor.7400166 · DOI
- Lange-Dohna, 2003, Cloning and expression of the rat BACE1 promoter, J. Neurosci. Res., 73, 73, 10.1002/jnr.10639 · DOI
- Leuba, 2005, Neuronal and nonneuronal quantitative BACE immunocytochemical expression in the entorhinohippocampal and frontal regions in Alzheimer's disease, Dement. Geriatr. Cogn. Disord., 19, 171, 10.1159/000083496 · DOI
- Li, 2000, Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice, J. Clin. Invest., 106, 523, 10.1172/JCI10370 · DOI · Paper page
- Li, 2004, Cleavage of amyloid-beta precursor protein and amyloid-beta precursor-like protein by BACE1, J. Biol. Chem., 279, 10542, 10.1074/jbc.M310001200 · DOI · Paper page
- Li, 1991, Direct interaction between Sp1 and the BPV enhancer E2 protein mediates synergistic activation of transcription, Cell, 65, 493, 10.1016/0092-8674(91)90467-D · DOI · Paper page
- Li, 2002, Interaction of Huntington disease protein with transcriptional activator Sp1, Mol. Cell Biol., 22, 1277, 10.1128/MCB.22.5.1277-1287.2002 · DOI · Paper page
- Li, 2006, Control of APP processing and Abeta generation level by BACE1 enzymatic activity and transcription, FASEB J., 20, 285, 10.1096/fj.05-4986com · DOI
- Lichtenthaler, 2003, The cell adhesion protein P-selectin glycoprotein ligand-1 is a substrate for the aspartyl protease BACE1, J. Biol. Chem., 278, 48713, 10.1074/jbc.M303861200 · DOI · Paper page
- Lin, 2000, Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid precursor protein, Proc. Natl. Acad. Sci. U.S.A., 97, 1456, 10.1073/pnas.97.4.1456 · DOI · Paper page
- Liu, 2004, NF-kappaB site interacts with Sp factors and up-regulates the NR1 promoter during neuronal differentiation, J. Biol. Chem., 279, 17449, 10.1074/jbc.M311267200 · DOI
- Liu, 2002, Glu11 site cleavage and N-terminally truncated Abeta production upon BACE overexpression, Biochemistry, 41, 3128, 10.1021/bi015800g · DOI · Paper page
- Liu, 2002, Identification and functional analysis of the rat caspase-3 gene promoter, J. Biol. Chem., 277, 8273, 10.1074/jbc.M110768200 · DOI
- Lukiw, 1994, Protein–DNA interactions in the promoter region of the amyloid precursor protein (APP) gene in human neocortex, Mol. Brain Res., 22, 121, 10.1016/0169-328X(94)90039-6 · DOI
- Luo, 2003, BACE1 (beta-secretase) knockout mice do not acquire compensatory gene expression changes or develop neural lesions over time, Neurobiol. Dis., 14, 81, 10.1016/S0969-9961(03)00104-9 · DOI · Paper page
- Manzella, 1991, Insulin induction of ornithine decarboxylase. Importance of mRNA secondary structure and phosphorylation of eucaryotic initiation factors eIF-4B and eIF-4E, J. Biol. Chem., 266, 2383, 10.1016/S0021-9258(18)52255-9 · DOI · Paper page
- Marcinkiewicz, 2000, Coordinated expression of beta-amyloid precursor protein and the putative beta-secretase BACE and alpha-secretase ADAM10 in mouse and human brain, J. Neurochem., 75, 2133, 10.1046/j.1471-4159.2000.0752133.x · DOI · Paper page
- Mash, 1985, Loss of M2 muscarinic receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation, Science, 228, 1115, 10.1126/science.3992249 · DOI · Paper page
- Mitsuda, 1997, Transcriptional regulation of the mouse presenilin-1 gene, J. Biol. Chem., 272, 23489, 10.1074/jbc.272.38.23489 · DOI
- Niino, 2001, Amelioration of experimental autoimmune encephalomyelitis in C57BL/6 mice by an agonist of peroxisome proliferator-activated receptor-gamma, J. Neuroimmunol., 116, 40, 10.1016/S0165-5728(01)00285-5 · DOI · Paper page
- Nitsch, 1994, Role of neurotransmission in the regulation of amyloid beta-protein precursor processing, Biochem. Pharmacol., 47, 1275, 10.1016/0006-2952(94)90325-5 · DOI
- Nordberg, 1992, Neuroreceptor changes in Alzheimer's disease, Cerebrovasc. Brain Metab. Rev., 4, 303
- Nowak, 2006, The transcription factor Yin Yang1 is an activator of BACE1 expression, J. Neurochem., 96, 1696, 10.1111/j.1471-4159.2006.03692.x · DOI
- Oei, 2001, Transcription factor Yin Yang 1 stimulates poly(ADP-ribosyl)ation and DNA repair, Biochem. Biophys. Res. Commun., 284, 450, 10.1006/bbrc.2001.4985 · DOI
- Ohno, 2004, BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer's disease, Neuron, 41, 27, 10.1016/S0896-6273(03)00810-9 · DOI · Paper page
- Palko, 2004, The Yin Yang-1 (YY1) protein undergoes a DNA-replication-associated switch in localization from the cytoplasm to the nucleus at the onset of S phase, J. Cell Sci., 117, 465, 10.1242/jcs.00870 · DOI
- Parks, 1996, The serotonin 1a receptor gene contains a TATA-less promoter that responds to MAZ and Sp1, J. Biol. Chem., 271, 4417, 10.1074/jbc.271.8.4417 · DOI · Paper page
- Pastorino, 2004, BACE (beta-secretase) modulates the processing of APLP2 in vivo, Mol. Cell. Neurosci., 25, 642, 10.1016/j.mcn.2003.12.013 · DOI
- Pedersen, 1996, Amyloid β protein reduces acetylcholine synthesis in a cell line derived from cholinergic neurons of the basal forebrain, Proc. Natl. Acad. Sci. U.S.A., 93, 8068, 10.1073/pnas.93.15.8068 · DOI · Paper page
- Pennypacker, 1998, Cloning and characterization of the presenilin-2 gene promoter, Mol. Brain Res., 56, 57, 10.1016/S0169-328X(98)00028-X · DOI
- Perkins, 1993, A cooperative interaction between NF-kappa B and Sp1 is required for HIV-1 enhancer activation, EMBO J., 12, 3551, 10.1002/j.1460-2075.1993.tb06029.x · DOI · Paper page
- Pollwein, 1993, Overlapping binding sites of two different transcription factors in the promoter of the human gene for the Alzheimer amyloid precursor protein, Biochem. Biophys. Res. Commun., 190, 637, 10.1006/bbrc.1993.1096 · DOI
- Preece, 2003, Beta-secretase (BACE) and GSK-3 mRNA levels in Alzheimer's disease, Mol. Brain Res., 116, 155, 10.1016/S0169-328X(03)00233-X · DOI
- Puglielli, 2003, Ceramide stabilizes beta-site amyloid precursor protein-cleaving enzyme 1 and promotes amyloid beta-peptide biogenesis, J. Biol. Chem., 278, 19777, 10.1074/jbc.M300466200 · DOI · Paper page
- Ricote, 1999, The peroxisome proliferator-activated receptor (PPARγ) as a regulator of monocyte/macrophage function, J. Leukocyte Biol., 66, 733, 10.1002/jlb.66.5.733 · DOI · Paper page
- Rogers, 2004, Differential utilization of upstream AUGs in the beta-secretase mRNA suggests that a shunting mechanism regulates translation, Proc. Natl. Acad. Sci. U.S.A., 101, 2794, 10.1073/pnas.0308576101 · DOI
- Roßner, 2001, Neuronal and glial beta-secretase (BACE) protein expression in transgenic Tg2576 mice with amyloid plaque pathology, J. Neurosci. Res., 64, 437, 10.1002/jnr.1095 · DOI
- Roßner, 1998, The regulation of APP metabolism by cholinergic mechanisms and neurotrophin receptor signaling, Prog. Neurobiol., 56, 541, 10.1016/S0301-0082(98)00044-6 · DOI · Paper page
- Sabo, 1999, Regulation of beta-amyloid secretion by FE65, an amyloid protein precursor-binding protein, J. Biol. Chem., 274, 7952, 10.1074/jbc.274.12.7952 · DOI · Paper page
- Sastre, 2003, Nonsteroidal anti-inflammatory drugs and peroxisome proliferator-activated receptor-gamma agonists modulate immunostimulated processing of amyloid precursor protein through regulation of beta-secretase, J. Neurosci., 23, 9796, 10.1523/JNEUROSCI.23-30-09796.2003 · DOI · Paper page
- Sastre, 2006, NSAIDs repress BACE1 gene promoter activity by activation of the peroxisome proliferator-activated receptor-γ (PPARγ), Proc. Natl. Acad. Sci. U.S.A., 103, 443, 10.1073/pnas.0503839103 · DOI · Paper page
- Saunders, 1999, BACE Maps to Chromosome 11 and a BACE homolog, BACE2, reside in the obligate Down syndrome region of chromosome 21, Science, 286, 1255a, 10.1126/science.286.5443.1255a · DOI
- Selkoe, 2003, Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics, Ann. Rev. Pharmacol. Toxicol., 43, 545, 10.1146/annurev.pharmtox.43.100901.140248 · DOI · Paper page
- Shi, 1991, Transcriptional repression by YY1, a human GLI-Kruppel-related protein, and relief of repression by adenovirus E1A protein, Cell, 67, 377, 10.1016/0092-8674(91)90189-6 · DOI · Paper page
- Sinha, 1999, Purification and cloning of amyloid precursor protein beta-secretase from human brain, Nature, 402, 537, 10.1038/990114 · DOI · Paper page
- Sun, 2002, Localization of beta-secretase memapsin 2 in the brain of Alzheimer's patients and normal aged controls, Exp. Neurol., 175, 10, 10.1006/exnr.2002.7875 · DOI
- Svensson, 1992, Characterization of muscarinic receptor subtypes in Alzheimer and control brain cortices by selective muscarinic antagonists, Brain Res., 596, 142, 10.1016/0006-8993(92)91541-L · DOI
- Tanahashi, 2001, Three novel alternatively spliced isoforms of the human beta-site amyloid precursor protein cleaving enzyme (BACE) and their effect on amyloid beta-peptide production, Neurosci. Lett., 307, 9, 10.1016/S0304-3940(01)01912-7 · DOI · Paper page
- Tohgi, 1999, The methylation status of cytosines in a tau gene promoter region alters with age to downregulate transcriptional activity in human cerebral cortex, Neurosci. Lett., 275, 89, 10.1016/S0304-3940(99)00731-4 · DOI
- Toliver-Kinsky, 2000, Nuclear factor kappaB/p49 is a negative regulatory factor in nerve growth factor-induced choline acetyltransferase promoter activity in PC12 cells, J. Neurochem., 75, 2241, 10.1046/j.1471-4159.2000.0752241.x · DOI
- Tyler, 2002, Alpha- and beta-secretase: profound changes in Alzheimer's disease, Biochem. Biophys. Res. Commun., 299, 373, 10.1016/S0006-291X(02)02635-9 · DOI · Paper page
- Watson, 2005, Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study, Am. J. Geriatr. Psychiatry, 13, 950
- Whitehouse, 1986, Cholinergic receptors in aging and Alzheimer's disease, Prog. Neuro-Psychopharmacol. Biol. Psychat., 10, 665, 10.1016/0278-5846(86)90035-7 · DOI
- Willis, 1999, Translational control of growth factor and proto-oncogene expression, Int. J. Biochem. Cell Biol., 31, 73, 10.1016/S1357-2725(98)00133-2 · DOI
- Wong, 2005, beta subunits of voltage-gated sodium channels are novel substrates of BACE1 and gamma-secretase, J. Biol. Chem., 280, 23009, 10.1074/jbc.M414648200 · DOI · Paper page
- Xing, 1997, TNF alpha-mediated inhibition and reversal of adipocyte differentiation is accompanied by suppressed expression of PPARgamma without effects on Pref-1 expression, Endocrinology, 138, 2776, 10.1210/en.138.7.2776 · DOI
- Yan, 2003, Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer's disease, J. Neurosci., 23, 7504, 10.1523/JNEUROSCI.23-20-07504.2003 · DOI · Paper page
- Yan, 2001, BACE2 functions as an alternative alpha-secretase in cells, J. Biol. Chem., 276, 34019, 10.1074/jbc.M105583200 · DOI · Paper page
- Yasojima, 2001, Relationship between beta amyloid peptide generating molecules and neprilysin in Alzheimer disease and normal brain, Brain Res., 919, 115, 10.1016/S0006-8993(01)03008-6 · DOI · Paper page
- Yeh, 2003, Association of transcription factor YY1 with the high molecular weight Notch complex suppresses the transactivation activity of Notch, J. Biol. Chem., 278, 41963, 10.1074/jbc.M304353200 · DOI
- Zambrano, 1997, Interaction of the phosphotyrosine interaction/phosphotyrosine binding-related domains of Fe65 with wild-type and mutant Alzheimer's beta-amyloid precursor proteins, J. Biol. Chem., 272, 6399, 10.1074/jbc.272.10.6399 · DOI
- Zambrano, 1997, DNA-binding protein Pur alpha and transcription factor YY1 function as transcription activators of the neuron-specific FE65 gene promoter, Biochem. J., 328, 293, 10.1042/bj3280293 · DOI
- Zohar, 2003, Quantification and distribution of beta-secretase alternative splice variants in the rat and human brain, Mol. Brain Res., 115, 63, 10.1016/S0169-328X(03)00182-7 · DOI · Paper page
- Zohar, 2005, Age-dependent differential expression of BACE splice variants in brain regions of tg2576 mice, Neurobiol. Aging, 26, 1167, 10.1016/j.neurobiolaging.2004.10.005 · DOI · Paper page
- Zuchner, 2004, Beta-secretase BACE1 is differentially controlled through muscarinic acetylcholine receptor signaling, J. Neurosci. Res., 77, 250, 10.1002/jnr.20152 · DOI
- Zuchner, 2005, Down-regulation of muscarinic acetylcholine receptor M2 adversely affects the expression of Alzheimer's disease-relevant genes and proteins, J. Neurochem., 95, 20, 10.1111/j.1471-4159.2005.03335.x · DOI
Cited by
Faghihi, M. A., Modarresi, F., Khalil, A. M., Wood, D. E., Sahagan, B. G., Morgan, T. E., Finch, C. E., St. Laurent III, G., Kenny, P. J., & Wahlestedt, C. (2008) · Nature Medicine · doi:10.1038/nm1784 · Cited by 1,416
Hébert, S. S., Horré, K., Nicolaï, L., Papadopoulou, A. S., Mandemakers, W., Silahtaroglu, A. N., Kauppinen, S., Delacourte, A., & De Strooper, B. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710263105 · Cited by 1,183
APP mouse models for Alzheimer’s disease preclinical studies.
Sasaguri, H., Nilsson, P., Hashimoto, S., Nagata, K., Saito, T., De Strooper, B., Hardy, J., Vassar, R., Winblad, B., & Saido, T. C. (2017) · The EMBO Journal · doi:10.15252/embj.201797397 · Cited by 793
The β-Secretase BACE1 in Alzheimer’s Disease
Hampel, H., Vassar, R., De Strooper, B., Hardy, J., Willem, M., Singh, N., Zhou, J., Yan, R., Vanmechelen, E., De Vos, A., et al. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.02.001 · Cited by 694
Wang, W.-X., Rajeev, B. W., Stromberg, A. J., Ren, N., Tang, G., Huang, Q., Rigoutsos, I., & Nelson, P. T. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.5065-07.2008 · Cited by 701
Metadata
- Authors
- Roßner, S., Sastre, M., Bourne, K., & Lichtenthaler, S. F.
- Venue
- Progress in Neurobiology
- Publisher
- Elsevier BV
- Published
- 2006-06
- Volume
- 79
- Issue
- 2
- Pages
- 95-111
- ISSN
- 0301-0082
- Cited by
- 169
- References
- 26
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Transcriptional and translational regulation of BACE1 expression—Implications for Alzheimer's disease. https://app.cochat.ai/papers/10.1016/j.pneurobio.2006.06.001
- The paper
- Roßner, S., Sastre, M., Bourne, K., & Lichtenthaler, S. F. (2006). Transcriptional and translational regulation of BACE1 expression—Implications for Alzheimer's disease. Progress in Neurobiology. https://doi.org/10.1016/j.pneurobio.2006.06.001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.